Presentation Operator Message
Operator (Operator)
Hello, and welcome to Intellia Therapeutics' Fourth Quarter and Full Year 2025 Conference Call. My name is Drew, and I will be your conference operator
I
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.83 USD | -0.29% |
|
+5.33% | +53.84% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
Published on 02/26/2026 at 05:08 pm EST - Modified on 02/26/2026 at 10:32 pm EST
Presentation Operator Message
Operator (Operator)
Hello, and welcome to Intellia Therapeutics' Fourth Quarter and Full Year 2025 Conference Call. My name is Drew, and I will be your conference operator
I
Select your edition
All financial news and data tailored to specific country editions